A major clinical trial, which included 13 patients from National University Hospital, showed that the drug lecanemab slowed cognitive and functional decline in participants aged 50 to 90 with early Alzheimer’s disease.
In The Straits Times’ The Big Story, Multimedia Correspondent Cheow Sue-Ann speaks with Associate Professor Christopher Chen, a Visiting Consultant in the Department of Psychological Medicine at NUH about the research.